Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hamilton Health Sciences Corporation
With
Pfizer
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatient with primary Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) GSP plus at least one of the following comorbid DSM-IV anxiety disorders:
* panic disorder with agoraphobia
* obsessive compulsive disorder
* major depressive disorder
* generalized anxiety disorder
Score on LSAS \> 50
Score on MADRS \< 25
You may not be if
Any other primary AXIS-I diagnosis
Criteria for alcohol/substance abuse/dependence
History (Hx) of bipolar disorder, schizophrenia or other psychotic disorder
A comorbid Axis II cluster A personality disorder
Current increased risk of concomitant suicide
Allergy/previous intolerance during an adequate trial (50mg/day for minimum of 4 weeks) of sertraline
Participation in any clinical trial 30 days prior to entering the study
Unable to tolerate being free of/shows signs of withdrawal from benzodiazepines for 4 weeks
Hx of seizures
Thyroid problems
Clareo Health | Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
